(Q34423459)

2 August 2017

title

Contribution of biomarkers to personalized medicine (English)

1 reference

2 August 2017

0 references

personalized medicine

1 reference

Daniel F Hayes

1

1 reference

2 August 2017

publication date

20 December 2010

1 reference

2 August 2017

published in

Breast Cancer Research

1 reference

2 August 2017

volume

12 Suppl 4

1 reference

2 August 2017

page(s)

S3

1 reference

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005723

Randomized clinical trials with biomarkers: design issues

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005723

Use of archived specimens in evaluation of prognostic and predictive biomarkers

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005723

The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005723

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005723

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005723

Uses and abuses of tumor markers in the diagnosis, monitoring, and treatment of primary and metastatic breast cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005723

Clinical trial designs for predictive marker validation in cancer treatment trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005723

Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005723

Reporting recommendations for tumor marker prognostic studies (REMARK).

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FBCR2732

21 January 2018

Identifiers

DOI

10.1186/BCR2732

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference

2 August 2017

1 reference